Northstar intends through this effort to complete scale-up production of MO-99 via the neutron capture process using enriched molybdenum-98 target material by 1) obtaining approval of a next…
Ended Cooperative Agreement Awarded Last action
- Award ID
- DENA0004011
- Recipient
-
Northstar Medical Technologies, LLC UEI RP3JVPT94155
- Awarding agency
-
National Nuclear Security Administration
Department of Energy
- Obligated
- $32,615,000
Award facts
- Assistance listing
- 81.009 Molybdenum-99 Program
- Completion date
- Originally
- Funding
-
- $10,154,573.13 Federal
- $22,460,426.87 Non-federal
- Place of performance
- Beloit, WI 53511, USA
Award details come from USAspending.gov.
Description
Northstar intends through this effort to complete scale-up production of MO-99 via the neutron capture process using enriched molybdenum-98 target material by 1) obtaining approval of a next generation TC-99M separation system known internally as orion. Northstar will continue use of enriched material that is nominally enriched to at least 95% in the stable isotope molybdenum-98. This enrichment boost increases the irradiation yield approximately four (4) fold with the same target load mass. Additionally, northstar 2) will complete establishment of automated target dissolution and filling systems by installing an automated customer shipping system at our beloit, WI facility. A further project objective also is to 3) complete scale-up of the recovery and reclamation process to reclaim enriched molybdenum-98 from spent generator and processing material allowing for a significantly lower effective raw material costs of target material. We will 4) install quality control equipment at our murr facility to accelerate MO-99 product release to customers and eliminate reliance on a third party laboratory. Further, we will 5) acquire additional enriched molybdenum-98 target material to meet all testing and scale-up needs.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $295,546 | -$295,546 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | -$172,844,027 | |
| Amendment | $7,500 | $0 | |
| Amendment | -$1,000,000 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | -$5,448,473 | $0 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $0 | $16,300,000 | |
| Amendment | $16,300,000 | $16,300,000 | |
| Amendment | -$16,300,000 | $16,300,000 | |
| Original award | $16,300,000 | $16,300,000 |
Show all 19
Quick answers
Who received award DENA0004011?
DENA0004011 was awarded to Northstar Medical Technologies, LLC by National Nuclear Security Administration (Department of Energy) on September 2, 2021.
How much is award DENA0004011 worth?
$32,615,000 has been obligated on DENA0004011: $10,154,573 in federal funding and $22,460,427 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award